Literature DB >> 22317916

Proteome folding and aggregation.

Michele Vendruscolo1.   

Abstract

The description of protein folding at the proteome level requires further principles in addition to those that govern this phenomenon for individual molecules. An important aspect of the increased complexity of the folding process in the cellular environment is that proteins tend to be metastable against aggregation, as they are often expressed at levels at which they are poorly soluble. The maintenance of the solubility of the proteome requires the coordinated intervention of a range of quality control mechanisms, which include molecular chaperones, trafficking and degradation pathways, post-translational modifications and transcriptional and translational control. As these regulatory mechanisms should always be active to keep proteins in their soluble state, their impairment upon ageing or environmental stress can lead to the disruption of protein homeostasis resulting in uncontrolled widespread aggregation and disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22317916     DOI: 10.1016/j.sbi.2012.01.005

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  19 in total

1.  Protein structural dynamics at the gas/water interface examined by hydrogen exchange mass spectrometry.

Authors:  Yiming Xiao; Lars Konermann
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

2.  Glutathionylation primes soluble glyceraldehyde-3-phosphate dehydrogenase for late collapse into insoluble aggregates.

Authors:  Mirko Zaffagnini; Christophe H Marchand; Marco Malferrari; Samuel Murail; Sara Bonacchi; Damiano Genovese; Marco Montalti; Giovanni Venturoli; Giuseppe Falini; Marc Baaden; Stéphane D Lemaire; Simona Fermani; Paolo Trost
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

3.  Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors.

Authors:  Lauren M Meyers; Casey Krawic; Michal W Luczak; Anatoly Zhitkovich
Journal:  Toxicol Appl Pharmacol       Date:  2022-04-30       Impact factor: 4.460

4.  Early folding events protect aggregation-prone regions of a β-rich protein.

Authors:  Ivan L Budyak; Beena Krishnan; Anna M Marcelino-Cruz; Mylene C Ferrolino; Anastasia Zhuravleva; Lila M Gierasch
Journal:  Structure       Date:  2013-03-05       Impact factor: 5.006

5.  Protein quality control acts on folding intermediates to shape the effects of mutations on organismal fitness.

Authors:  Shimon Bershtein; Wanmeng Mu; Adrian W R Serohijos; Jingwen Zhou; Eugene I Shakhnovich
Journal:  Mol Cell       Date:  2012-12-06       Impact factor: 17.970

Review 6.  Folding the proteome.

Authors:  Esther Braselmann; Julie L Chaney; Patricia L Clark
Journal:  Trends Biochem Sci       Date:  2013-06-11       Impact factor: 13.807

7.  The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.

Authors:  Lucía F Zacchi; Hui-Chuan Wu; Samantha L Bell; Linda Millen; Adrienne W Paton; James C Paton; Philip J Thomas; Michal Zolkiewski; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

8.  Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates.

Authors:  Hyun Jin Min; Eun Ae Ko; Jie Wu; Eun Sung Kim; Min Kyung Kwon; Man Sup Kwak; Ji Eun Choi; Jong Eun Lee; Jeon-Soo Shin
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

9.  Recognition of enzymes lacking bound cofactor by protein quality control.

Authors:  Adrián Martínez-Limón; Marion Alriquet; Wei-Han Lang; Giulia Calloni; Ilka Wittig; R Martin Vabulas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-12       Impact factor: 11.205

10.  Evolutionary optimization of protein folding.

Authors:  Cédric Debès; Minglei Wang; Gustavo Caetano-Anollés; Frauke Gräter
Journal:  PLoS Comput Biol       Date:  2013-01-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.